Epidemiology and risk factors for Clostridium difficile infection in children

Pediatr Infect Dis J. 2011 Jul;30(7):580-4. doi: 10.1097/INF.0b013e31820bfb29.

Abstract

Background: Pediatric Clostridium difficile infection (CDI)-related hospitalizations are increasing. We sought to describe the epidemiology of pediatric CDI at a quaternary care hospital.

Methods: Nested case-control study within a cohort of children <18 years tested for C. difficile between January and August 2008. The study included patients who were ≥ 1 year with a positive test and diarrhea; those without diarrhea (ie, presumed colonization) were excluded. Two unmatched controls per case were randomly selected from patients ≥ 1 year with a negative test. Potential predictors of CDI included age, gender, comorbidities, prior hospitalization, receipt of C. difficile-active antibiotics in the prior 24 hours, and recent (≤ 4 weeks) exposure to antibiotics or acid-blocking medications. Multivariate logistic regression models were created to identify independent predictors of CDI.

Results: Of 1891 tests performed, 263 (14%) were positive in 181 children. Ninety-five patients ≥ 1 year with CDI were compared with 238 controls. In multivariate analyses, predictors of CDI included solid organ transplant (odds ratio [OR], 8.09; 95% confidence interval [CI], 2.10-31.12), lack of prior hospitalization (OR, 8.43; 95% CI, 4.39-16.20), presence of gastrostomy or jejunostomy (G or J) tube (OR, 3.32; 95% CI 1.71-6.42), and receipt of fluoroquinolones (OR, 17.04; 95% CI, 5.86-49.54) or nonquinolone antibiotics (OR, 2.23; 95% CI, 1.18-4.20) in the past 4 weeks. Receipt of C. difficile-active antibiotics within 24 hours before testing was associated with a lower odds of CDI (OR, 0.22; 95% CI, 0.09-0.58).

Conclusions: Recent antibiotic exposure and certain comorbid conditions (solid organ transplant, presence of a gastrostomy or jejunostomy tube) were associated with CDI. Diagnostic testing has less utility in patients being treated with C. difficile-active antibiotics.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / adverse effects
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Clostridioides difficile / isolation & purification*
  • Clostridium Infections / epidemiology*
  • Cohort Studies
  • Female
  • Hospitals
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Massachusetts / epidemiology
  • Risk Factors
  • Surgical Procedures, Operative / adverse effects

Substances

  • Anti-Bacterial Agents